Unobtrusive continuous and quantitative assessment of Parkinson s disease hard...
Unobtrusive continuous and quantitative assessment of Parkinson s disease hard evidence for optimal disease management with information technologies
Sense4Care S.L. (S4C) is high-tech SME constituted in Barcelona in 2013 as a spin-off of the Universitat
Politècnica de Catalunya - BarcelonaTech (UPC) with a clear objective: taking to the market the results of several
research p...
ver más
SENSE4CARE
Desarrollo y comercializacion de servicios tecnologicos en el ambito del diseño y especialmente el desarrollo de dispositivos y software en...
TRL
4-5
| 139K€
Fecha límite participación
Sin fecha límite de participación.
Financiación
concedida
El organismo H2020 notifico la concesión del proyecto
el día 2015-11-30
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
PARK-IT 2.0
Unobtrusive Continuous and Quantitative Assessment of Parki...
999K€
Cerrado
TED2021-130174B-C33
DEFINICION DE METRICAS Y VALIDACION CLINICA DE UN SISTEMA DI...
117K€
Cerrado
RTC2019-007150-1
Solución sanitaria móvil basada en el perfil genético, análi...
288K€
Cerrado
PERFORM
A sophisticated multi parametric system for the continuous e...
9M€
Cerrado
SENSE-PARK
SENSE PARK Supporting and Empowering Parkinson patients in...
3M€
Cerrado
PD-Watch
Wearable technology for the selective detection and continuo...
71K€
Cerrado
Información proyecto PARK-IT
Duración del proyecto: 6 meses
Fecha Inicio: 2015-05-06
Fecha Fin: 2015-11-30
Líder del proyecto
SENSE4CARE
Desarrollo y comercializacion de servicios tecnologicos en el ambito del diseño y especialmente el desarrollo de dispositivos y software en...
TRL
4-5
| 139K€
Presupuesto del proyecto
71K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Sense4Care S.L. (S4C) is high-tech SME constituted in Barcelona in 2013 as a spin-off of the Universitat
Politècnica de Catalunya - BarcelonaTech (UPC) with a clear objective: taking to the market the results of several
research projects. UPC itself holds 5% of the shares of the company, and the rest belongs to professors,
researchers and investors. UPC was the Coordinator and main beneficiary of the FP7-ICT project called
REMPARK1 project, and has legally transferred the exploitation rights of the project results to S4C, with the aim
of commercialising a product that can dramatically improve the lives of Parkinson’s Disease (PD) sufferers.
The main result from the FP7-REMPARK project is the kinetic monitor PARK-IT, which can be exploited as a
standalone product. PARK-IT is a new gold-standard, continuous and quantitative monitoring medical device for
assessing the status of Parkinson Disease patients. PARK-IT device, based in movement detection and complex
algorithms, allows the doctors to precisely adjust the medication of PD patients, overcoming one of the main
problems that PD patients face. It constitutes a disruptive innovation answering to an unmet need.
The present innovation business project is therefore focused in taking this device to the market through a
clear and innovative business model.